News
GOOD NEWS FLASH
January 2023 Sementis has exciting news. We’re pleased to announce that we’ve been awarded a $3 million Federal...
-
-
News
Key steps to advance vaccine manufacturing technology
December 2022 Sementis are grateful and proud to have the support of DMTC Ltd to advance research and development...
-
News
Sementis’ quest for an Australian second-generation COVID-19 vaccine
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
-
News
New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses
September 2021 Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust...
-
News
Adelaide company Sementis will raise $10m to progress its Covid-19 vaccine candidate
August 2021 Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19...
-
News
Sementis and Enesi Pharma partner to develop needle-free vaccines
November 2018 Australian biotechnology firm Sementis has entered into a research and development (R&D) partnership...
-
News
UK pharma Enesi links with Australian biotech Sementis
November 2018 UK group Enesi Pharma has signed a deal with Australian biotech Sementis to develop solid dose versions...
-
News
Australian university, Sementis working on Zika vaccine
February 2016 The University of South Australia said on Tuesday it was working on a vaccine for the Zika virus with Australian...